Roche repurchases own shares held by rival Novartis
ZURICH: Swiss pharmaceuticals giant Roche said Thursday that it will buy back around one third of its voting capital currently held by rival Novartis as the two groups disentangle their ties for greater strategic flexibility. The two drug-makers said in separate statements that Roche would repurchase 53.3 million of its own shares currently held by Novartis … Read more